Chronic prostatitis and small intestinal bacterial overgrowth: Effect of rifaximin

Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
The Canadian Journal of Urology (Impact Factor: 0.98). 08/2011; 18(4):5826-30.
Source: PubMed


This pilot study determined the efficacy of rifaximin, a gut-directed antibiotic, in reducing chronic prostatitis (CP) and gastrointestinal (GI) symptoms in patients with CP type III. The prevalence of small intestinal bacterial overgrowth (SIBO) and irritable bowel syndrome (IBS) in patients with CP was also evaluated.
Chronic prostatitis patients were recruited and screened for SIBO and IBS using the lactulose breath test (LBT) and Rome II criteria, respectively. Patients with a positive LBT result and Chronic Prostatitis Symptom Index (CPSI) score ≥ 15 received rifaximin 550 mg three times daily for 10 days. The CPSI score and global improvement of CP and GI symptoms were ascertained at screening (ie, 7 days before therapy), at baseline immediately before therapy (ie, day 0), and on days 14 and 28.
Fourteen of 16 CP patients (88%) had a positive LBT result and were included in this therapeutic study (mean age, 41 years). Mean CPSI score significantly decreased from screening to day 28 (ie, 18 days after rifaximin treatment; p = 0.043). Mean abdominal pain and bloating scores were also significantly reduced on day 28 versus baseline (p = 0.010 and p = 0.003, respectively). Chronic prostatitis patients with IBS and SIBO had a statistically significant response as well.
Data from this pilot study suggest that SIBO and IBS are common in CP and that patients with CP and SIBO may benefit from rifaximin therapy. Further studies are warranted.

  • Source
    • "Probiotics are important to reduce gastrointestinal side-effects caused by the prolonged use of broad-band antibiotics. Considering that pathogens found in the prostate often derive from intestinal bacterial overgrowth, it is important to remark the role of probiotics in maintaining a regular intestinal bacterial flora [24]. Some authors have postulated that urethral dysbacteriosis is one of the primary causes of CP, further contributing to its recidivity and refractoriness [12]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bacterial prostatitis (BP) is a common condition accounting responsible for about 5-10% of all prostatitis cases; chronic bacterial prostatitis (CBP) classified as type II, are less common but is a condition that significantly hampers the quality of life, (QoL) because not only is it a physical condition but also a psychological distress. Commonly patients are treated with antibiotics alone, and in particular fluoroquinolones are suggested by the European Urology guidelines. This approach, although recommended, may not be enough. Thus, a multimodal approach to the prolonged antibiotic therapy may be helpful. 210 patients affected by chronic bacterial prostatitis were enrolled in the study. All patients were positive to Meares-Stamey test and symptoms duration was > 3 months. The purpose of the study was to evaluate the efficacy of a long lasting therapy with a fluoroquinolone in association with a nutraceutical supplement (prulifloxacin 600 mg for 21 days and an association of Serenoa repens 320 mg, Lactobacillus Sporogens 200 mg, Arbutin 100 mg for 30 days). Patients were randomized in two groups (A and B) receiving respectively antibiotic alone and an association of antibiotic plus supplement. Biological recurrence at 2 months in Group A was observed in 21 patients (27.6%) and in Group B in 6 patients (7.8%). Uropathogens found at the first follow-up were for the majority Gram – (E. coli and Enterobacter spp.). A statistically significant difference was found at the time of the follow-up between Group A and B in the NIH-CPSI questionnaire score, symptoms evidence and serum PSA. Broad band, short-lasting antibiotic therapy in association with a nutritional supplement (serenoa repens, lactobacillus sporogens and arbutin) show better control and recurrence rate on patients affected by chronic bacterial prostatitits in comparison with antibiotic treatment alone. Trial registration NCT02130713 Date of trial Registration: 30/04/2014
    Full-text · Article · Jul 2014 · BMC Urology
  • [Show abstract] [Hide abstract]
    ABSTRACT: To describe new developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome (CPPS). Symptoms in men with chronic prostatitis/CPPS appear to cluster into a group with primarily pelvic or localized disease, and a group with more systemic symptoms. Several other chronic pain conditions can be associated with chronic prostatitis/CPPS, including irritable bowel syndrome, fibromyalgia, and chronic fatigue syndrome. Markers of neurologic inflammation and autoimmune disease parallel changes in symptoms after treatment. Treatment options include new alpha-blockers, psychological intervention, and prostate-directed therapy. The areas of acupuncture and pelvic floor physical therapy/myofascial release have received increased recent attention and appear to be good options in these patients. Future therapy may include antibodies to mediators of neurogenic inflammation and even treatment of bacteria in the bowel. The diagnosis of chronic prostatitis/CPPS must include conditions traditionally outside the scope of urologic practice but important for the care of men with chronic pelvic pain. The treatment is best done using multiple simultaneous therapies aimed at the different aspects of the condition.
    No preview · Article · Sep 2013 · Current opinion in urology
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This study used electrophysiological measures of pre-stimulus effects that can occur prior to an unknown future event as an indicator of nonlocal intuition. Intuition in this context is considered as a process by which information normally outside the range of conscious awareness is detected at the cellular level by the heart, the brain, and the autonomic nervous system. This study extends the findings of previous experiments demonstrating that aspects of our physiology can respond to an emotionally engaging stimulus before it is actually experienced. The study evaluated a revised version of a roulette protocol, which included two pre-stimulus segments and included an analysis of the individual participant's data over eight separate trials in addition to a group-level analysis. We also assessed the potential effects of the moon phase on the pre-stimulus response outcomes and participant winning and amount won ratios. Data were collected under controlled laboratory conditions from 13 participants in 8 separate sessions using a modified version of a gambling paradigm protocol based on roulette. Half of the experimental sessions were conducted during the full moon phase and half during the new moon phase. Within each trial a total of three segments of physiological data were assessed. There were two separate pre-stimulus periods, pre-bet (4 sec) and postbet (12 sec), and a post-result period (6 sec). Participants were told that they were participating in a gambling experiment and were given an initial starting kitty and told they could keep any winnings over the course of 26 trials for each of the eight sessions. The physiological measures included the electrocardiogram (ECG), from which cardiac inter-beat-intervals (heart rate variability, HRV) were derived, and skin conductance. Before the participants participated in the first session, they completed the Cognitive Styles Index questionnaire, which assesses analytical vs intuitive styles. Overall, the results indicate that the revised protocol provides an effective objective measure for detecting a pre-stimulus response, which reflects a type of nonlocal intuition. We found significant differences between the win and loss responses in the aggregated physiological waveform data during both pre-stimulus segments, which provides important information about nonlocal intuition. On average, we detected a significant pre-stimulus response starting around 18 seconds prior to participants knowing the future outcome. Interestingly, there was not a strong overall relationship between the pre-stimulus responses and the amount of money the participants won or lost. We also found a significant difference in both pre-stimulus periods during the full moon phase but not in the new moon phase. The results suggest that the protocol is a reliable means of prompting physiological detection of pre-stimulus effects and can be used in future studies investigating aspects of nonlocal intuition. The findings also suggest that if participants had been able to become more attuned to their internal physiological responses, they would have performed much better on the betting choices they made.
    Full-text · Article · Mar 2014
Show more